Cite
Chimeric antigen receptor and bispecific T‐cell engager therapies in multiple myeloma patients with prior allogeneic transplantation.
MLA
Hammons, Lindsay, et al. “Chimeric Antigen Receptor and Bispecific T‐cell Engager Therapies in Multiple Myeloma Patients with Prior Allogeneic Transplantation.” British Journal of Haematology, vol. 204, no. 3, Mar. 2024, pp. 887–91. EBSCOhost, https://doi.org/10.1111/bjh.19244.
APA
Hammons, L., Haider, S., Portuguese, A. J., Banerjee, R., Szabo, A., Pasquini, M., Chhabra, S., Radhakrishnan, S., Mohan, M., Narra, R., Dong, J., Janz, S., Shah, N. N., Hamadani, M., D’Souza, A., Hari, P., & Dhakal, B. (2024). Chimeric antigen receptor and bispecific T‐cell engager therapies in multiple myeloma patients with prior allogeneic transplantation. British Journal of Haematology, 204(3), 887–891. https://doi.org/10.1111/bjh.19244
Chicago
Hammons, Lindsay, Shabi Haider, Andrew J. Portuguese, Rahul Banerjee, Aniko Szabo, Marcelo Pasquini, Saurabh Chhabra, et al. 2024. “Chimeric Antigen Receptor and Bispecific T‐cell Engager Therapies in Multiple Myeloma Patients with Prior Allogeneic Transplantation.” British Journal of Haematology 204 (3): 887–91. doi:10.1111/bjh.19244.